Skip to main content

CIZIGO , CIZINATE, CIZERE (Southern Cross Pharma Pty Ltd)

Product name
CIZIGO , CIZINATE, CIZERE
Date registered
Evaluation commenced
Decision date
Approval time
246 working days (255)
Active ingredients
cinnarizine/dimenhydrinate
Registration type
EOI
Indication
New combination

CIZIGO, CIZINATE, CIZERE (fixed-dose combination tablets) are indicated for the short-term, symptomatic treatment of vertigo of various causes, in adults who have not responded to alternative treatments.

Help us improve the Therapeutic Goods Administration site